• 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Glaukos

Glaukos is an ophthalmic device and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. We were the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), revolutionising the treatment and management of glaucoma. To date over 3M interventional devices have been implanted worldwide.

https://www.glaukos.com/au/
https://www.linkedin.com/company/glaukos-corporation/
https://www.facebook.com/GlaukosCorp/
https://www.instagram.com/glaukoscorporation/

Contact Details:
Name: Malaty Kittikhoun
Email: mkittikhoun@glaukos.com

Exhibitors

Abstract submission deadline extended

Important dates
Good News! Abstract Submission Now Open Until 21 February 2026